Jupiter Bioscience, a manufacturer of specialised organic compounds, on Tuesday said it has allotted 14.91 per cent stake to Ranbaxy Laboratories through issue of share warrants on preferential basis for Rs 46.70 crore (Rs 467 billion).
Ajit Mishra, vice president, research, Religare Broking, answers your queries.
"Defaulters are advised to pay tax arrears immediately," said the notice.
